Shed vs Henry Meds for Compounded Semaglutide: 2026 Comparison

Shed vs Henry Meds for Compounded Semaglutide: 2026 Comparison

Medically reviewed by Telehealth Ally Medical Review Team. Pricing and protocol data last verified April 2026.

Shed and Henry Meds occupy the same narrow corner of the telehealth market: compounded GLP-1 medications, cash-pay only, no brand-name options. Their prices are close. Their clinical models are not.

Henry Meds is cheaper for compounded semaglutide at $149/month versus Shed's $175/month. Shed is cheaper on tirzepatide ($325/month vs $349/month). The larger gap is clinical: Shed is a men's-health platform offering video consultations and TRT co-management that Henry Meds does not provide. For men managing weight gain and low testosterone simultaneously, Shed's integrated model is a genuine clinical advantage. For everyone else, Henry Meds' lower semaglutide price and async simplicity win.

How do Shed and Henry Meds compare on price?

Henry Meds undercuts Shed on compounded semaglutide by $26/month. That gap inverts on tirzepatide, where Shed charges $325/month versus Henry Meds' $349/month — a $24/month savings. Both providers price their medications all-in, with consultation and shipping included.

Pricing last verified April 2026. We update pricing data monthly.

	Shed	Henry Meds
Compounded semaglutide	$175/mo	$149/mo
Compounded tirzepatide	$325/mo	$349/mo
Consultation	Included	Included
Shipping	Included	Included
Loyalty discount	No	$129/mo at 6+ months
TRT co-management	Yes	No
Brand-name GLP-1 options	No	No
Video consultations	Yes (scheduled)	No (async only)

Henry Meds' semaglutide loyalty discount applies at six months: patients who stay continuously pay $129/month — a $240/year reduction against the standard rate. Shed offers no equivalent, making Henry Meds increasingly cost-competitive for patients who remain on semaglutide long-term.

Over a 12-month period, the semaglutide cost differential works out like this: Henry Meds patients who qualify for the loyalty discount pay $149/month for six months ($894) and $129/month for the remaining six months ($774) — a total of $1,668. Shed patients pay $175/month for the same year — $2,100. That is a $432/year difference.

What medications do Shed and Henry Meds offer?

Both providers offer compounded semaglutide and compounded tirzepatide only. Neither offers brand-name medications — no Ozempic, Wegovy, Mounjaro, or Zepbound. There is no insurance pathway at either provider.

Both source from 503B-registered outsourcing facilities, which are FDA-inspected and required to follow current Good Manufacturing Practices (cGMP). This is a higher quality standard than traditional 503A compounding pharmacies.

The regulatory environment for compounded GLP-1s is active. The FDA has been enforcing restrictions on compounding as brand-name drug supply normalizes. As of April 2026, compounded semaglutide availability is declining under FDA enforcement pressure. This affects all compounded GLP-1 providers — not Shed or Henry Meds specifically — but continuity of supply is a genuine uncertainty for patients planning long-term compounded medication access.

Medication	Shed	Henry Meds
Compounded semaglutide	✅ $175/mo	✅ $149/mo
Compounded tirzepatide	✅ $325/mo	✅ $349/mo
Brand semaglutide (Wegovy/Ozempic)	❌	❌
Brand tirzepatide (Zepbound/Mounjaro)	❌	❌
Insurance navigation	❌	❌

How do the clinical models differ?

Henry Meds is fully asynchronous. Patients complete an intake questionnaire, a licensed provider reviews the submission, and a prescription decision is returned within 24–48 hours. Follow-up care — dose adjustments, clinical questions — happens through provider messaging. There are no video consultations at any point in the Henry Meds care model.

Shed offers scheduled video consultations with men's health specialists. The intake includes a video appointment, not just a questionnaire. Follow-up video appointments are available for dose management and monitoring. For patients who want face-to-face clinical interaction — particularly on questions about hormonal interactions and metabolic health — Shed's model provides access that Henry Meds does not.

The second differentiator is Shed's men's health stack. Shed prescribes GLP-1 medications alongside testosterone replacement therapy (TRT), erectile dysfunction treatment, and hair loss care through a shared clinical team. Henry Meds prescribes GLP-1 medications only.

Hypogonadism and weight gain are not independent conditions — visceral fat suppresses testosterone production, and low testosterone contributes to fat accumulation and insulin resistance. A prescribing team that sees both sides of that picture can make more informed decisions than two separate providers managing each condition in isolation. GLP-1 therapy and TRT both affect body composition; the interactions can be significant.

For men who are already on TRT or are considering it alongside GLP-1 therapy, Shed's integrated model provides clinical coordination that is difficult to replicate by combining two separate async platforms.

Clinical factor	Shed	Henry Meds
Consultation model	Video (scheduled)	Async only
Prescription turnaround	24–48 hours	24–48 hours
TRT co-management	Yes	No
ED treatment	Yes	No
Lab ordering	Yes (additional cost)	No
Coaching or lifestyle program	No	No

Who is Shed for?

Shed's case is strongest for a specific patient: a man dealing with both weight gain and low testosterone, who wants a single clinical team managing both conditions.

• Men considering TRT and GLP-1 therapy simultaneously — Shed's physicians understand the metabolic and hormonal interplay between these treatments. Managing both through one clinical relationship, with video access, reduces the coordination risk of juggling separate providers.
• Men who want video consultations — Shed's scheduled video model provides a level of clinical interaction that no other major compounded GLP-1 provider at this price point offers.
• Patients who prioritize tirzepatide cost — At $325/month, Shed is $24/month cheaper than Henry Meds on compounded tirzepatide.
• Men managing multiple conditions — ED treatment and hair loss care available through the same platform as GLP-1 and TRT.

Shed is not the right fit if you are not male (Shed's platform is men-only), if you want the lowest-cost semaglutide option (Henry Meds is $26/month cheaper), if you live in one of the 8 states Shed does not serve, or if you need brand-name GLP-1 medications.

Who is Henry Meds for?

Henry Meds is the right choice when low cost and simplicity are the priorities.

• Patients seeking the lowest semaglutide price — $149/month is among the lowest available from a legitimate compounded GLP-1 provider, matching Ro at the semaglutide tier.
• Long-term semaglutide patients — The loyalty discount at six months drops the rate to $129/month, making Henry Meds significantly cheaper than Shed over a full year.
• Non-male patients — Henry Meds serves all adults. Shed's platform is men-only.
• Patients comfortable with async-only care — The model is straightforward: intake, prescription, provider messaging for follow-up. No video is required or available.
• Patients in all 50 states — Henry Meds' broader geographic footprint is an advantage over Shed's 42-state coverage.

How does state availability compare?

Shed operates in 42 states as of April 2026. Eight states are not served. Henry Meds operates in most states — coverage is broader than Shed's. Patients in states where Shed does not operate have no alternative but to use another provider.

State availability at both providers can change. Verify your state on each provider's website before starting an intake.

How We Evaluated

We compared Shed and Henry Meds across five dimensions: all-in monthly pricing at each medication tier, formulary and regulatory status, clinical support model, state availability, and platform capabilities. Pricing was verified against each provider's public website in April 2026. Telehealth Ally has no commercial relationship with either provider — editorial assessments are independent.

Pricing and protocol data sourced from Shed's and Henry Meds' public websites, verified April 2026. We have no commercial relationship with either provider.

Summary: Shed vs Henry Meds at a glance

Factor	Shed	Henry Meds
Compounded semaglutide	$175/mo	$149/mo
Compounded tirzepatide	$325/mo	$349/mo
Loyalty discount	❌	✅ $129/mo at 6+ months
Video consultations	✅	❌
TRT co-management	✅	❌
Non-male patients served	❌	✅
State availability	42 states	Most states
Brand-name medications	❌	❌
Insurance navigation	❌	❌

Frequently Asked Questions

Which is cheaper: Shed or Henry Meds? It depends on the medication. Henry Meds is cheaper for compounded semaglutide at $149/month versus Shed's $175/month — a $26/month difference. Shed is cheaper for compounded tirzepatide at $325/month versus Henry Meds' $349/month. For long-term semaglutide patients, Henry Meds' loyalty discount (dropping to $129/month after six months) makes the gap even larger over time.

Can Shed prescribe both GLP-1 and TRT together? Yes. Shed is one of the few telehealth platforms that co-manages GLP-1 medications alongside testosterone replacement therapy through a shared clinical team. This is a meaningful advantage for men dealing with both weight gain and hypogonadism — conditions that frequently overlap and interact metabolically. Henry Meds prescribes GLP-1 medications only and does not offer TRT.

Is Shed available in my state? Shed operates in 42 states as of April 2026. Eight states are currently not served. Check Shed's website for current state availability before starting the intake process, as this can change.

What pharmacy does Shed use? Shed ships from partner compounding pharmacies reported to follow quality standards consistent with PCAB accreditation and 503B outsourcing facility requirements. Specific pharmacy names should be confirmed directly with Shed during the consultation process.

Does Henry Meds offer tirzepatide? Yes. Henry Meds offers compounded tirzepatide at $349/month from 503B-registered pharmacies. Compounded tirzepatide is not FDA-approved as a finished drug product — it is prepared by FDA-inspected outsourcing facilities following cGMP standards. The active ingredient (tirzepatide) is the same as in FDA-approved Mounjaro and Zepbound.

Related Resources

• Shed Review 2026 — Full Shed assessment, clinical model, and who it's best for
• Henry Meds Review 2026 — Full Henry Meds analysis and budget GLP-1 context
• Henry Meds vs Hims for GLP-1 — How Henry Meds stacks up against another major competitor
• Compounded Semaglutide Providers Roundup — All major compounded GLP-1 providers compared